Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07756489Not ApplicableNot Yet Recruiting

SECURE Post-Market Study

Role: lead

NCT07277946Not ApplicableRecruiting

AtraUmatic Laparoscopic HerNia Repair Clinical Investigation to Evaluate the Safety and Performance of The ECLIPSIUM System for Mesh Fixation IDE

Role: lead

NCT06042205Not ApplicableActive Not Recruiting

TISSIUM™ Atraumatic Hernia Repair System (TAHRS) Pilot Study

Role: lead

NCT04327154Not ApplicableCompleted

TISSIUM's Nerve Coaptation Device First-in-Human Clinical Trial

Role: lead

All 4 trials loaded